Abstract:Abstract CRSIPR-Cas9 system has opened up the avenue to efficient genome editing 1–4 . However, together with known off-target effects, several concerns of current CRISPR-Cas9 platform, including severe DNA damage, cytotoxicity, and large genomic alteration, have emerged in recent reports 5–7 and establish a formidable obstacle to precisely model allele dosage effects of disease mutations and risk variants, especially mono-allelic effects, and correct them. Here, by developing an allele-specific indel monitor system (AIMS), we demonstrate that small and simple modification of conventional single-guide RNAs (sgRNAs) enable programmable tuning of CRISPR-Cas9 activities and alleviate such adverse effects. AIMS, which visualizes various indel events in two alleles separately in living cells, is convenient and accurate to determine the in vitro editing efficiency and revealed frequent mosaicism during genome editing. Using AIMS, we show that adding cytosine stretches to the 5’ end of conventional sgRNA efficiently reduced Cas9 activity in a length dependent manner. By combining systematic experiments and computational modeling, we established the quantitative relationships between the length of cytosine extension and multiple aspects of CRISPR-Cas9 system. In general, short cytosine extension dramatically relieves p53-dependent cytotoxicity and suppression of homology-directed repair (HDR) while relatively maintaining on-target activity. Long cytosine extension further decreases on-target activity, thereby maximizing mono-allelic editing, while conventional system typically induces bi-allelic editing. Furthermore, such downregulation of on-target activity contributes to downregulation of relative off-target activity and protection of HDR-allele from second off-target editing. Therefore, cytosine extension method finally enables both single-step generation of heterozygous single-nucleotide disease mutations from homozygous states in mouse ES cells and correction of heterozygous disease mutations in human iPS cells. Taken together, our study proposes updates of standard CRISPR-Cas9 platform in mammalian cells toward precise and safe genome editing in diverse applications.

An in situ cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

An <i>in situ</i> cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Development and application of CRISPR/Cas9 technologies in genomic editing.

dCas9-based gene editing for cleavage-free genomic knock-in of long sequences

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

Multiplex Genome Engineering Using CRISPR/Cas Systems

Crispr/Cas9-Loxp- Mediated Gene Editing As A Novel Site-Specific Genetic Manipulation Tool

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

Genome engineering using the CRISPR-Cas9 system

Ligase-mediated programmable genomic integration (L-PGI): an efficient site-specific gene editing system that overcomes the limitations of reverse transcriptase-based editing systems

Bacterial genome editing by coupling Cre-lox and CRISPR-Cas9 systems

In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells

Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editing

Efficient Inversions and Duplications of Mammalian Regulatory DNA Elements and Gene Clusters by CRISPR/Cas9